These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30690538)

  • 1. The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification.
    Henig O; Cooper CC; Kaye KS; Lephart P; Salimnia H; Taylor M; Hussain N; Hussain Z; Deeds K; Hayat U; Patel J; Pogue JM
    J Antimicrob Chemother; 2019 Jan; 74(Suppl 1):i32-i39. PubMed ID: 30690538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli.
    Henig O; Kaye KS; Chandramohan S; Cooper CC; Lephart P; Salimnia H; Taylor M; Pogue JM
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact.
    Schneider JG; Wood JB; Schmitt BH; Emery CL; Davis TE; Smith NW; Blevins S; Hiles J; Desai A; Wrin J; Bocian B; Manaloor JJ
    J Antimicrob Chemother; 2019 Jan; 74(Suppl 1):i16-i23. PubMed ID: 30690542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections.
    Descours G; Desmurs L; Hoang TLT; Ibranosyan M; Baume M; Ranc AG; Fuhrmann C; Dauwalder O; Salka W; Vandenesch F
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1573-1583. PubMed ID: 29808350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia.
    Walsh TL; Bremmer DN; Moffa MA; Trienski TL; Buchanan C; Stefano K; Hand C; Taylor T; Kasarda K; Shively NR; Bhanot N; Cheronis N; DiSilvio BE; Cho CY; Carr DR
    Infection; 2021 Jun; 49(3):511-519. PubMed ID: 33528813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the impact of the Accelerate Pheno™ system on time to result for differing antimicrobial stewardship intervention models in patients with gram-negative bloodstream infections.
    Elliott G; Malczynski M; Barr VO; Aljefri D; Martin D; Sutton S; Zembower TR; Postelnick M; Qi C
    BMC Infect Dis; 2019 Nov; 19(1):942. PubMed ID: 31699044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Accelerate Pheno™ system for identification and antimicrobial susceptibility testing of a panel of multidrug-resistant Gram-negative bacilli directly from positive blood cultures.
    Pantel A; Monier J; Lavigne JP
    J Antimicrob Chemother; 2018 Jun; 73(6):1546-1552. PubMed ID: 29474660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective implementation of the Accelerate Pheno™ system for positive blood cultures.
    Humphries R; Di Martino T
    J Antimicrob Chemother; 2019 Jan; 74(Suppl 1):i40-i43. PubMed ID: 30690541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system.
    Ullberg M; Özenci V
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):139-149. PubMed ID: 31641972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method.
    De Angelis G; Posteraro B; Menchinelli G; Liotti FM; Spanu T; Sanguinetti M
    J Antimicrob Chemother; 2019 Jan; 74(Suppl 1):i24-i31. PubMed ID: 30690539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience.
    De Socio GV; Belati A; Paggi R; D'Arpino A; Moretti A; Allegrucci F; Cenci E; Francisci D; Mencacci A
    New Microbiol; 2020 Jan; 43(1):6-12. PubMed ID: 32118280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Evaluation of the Accelerate Pheno System for Susceptibility Testing of Gram-Negative Bacteria Isolated from Blood Cultures.
    Patel YA; Kirn TJ; Weinstein MP; Uprety P
    Microbiol Spectr; 2021 Dec; 9(3):e0183621. PubMed ID: 34937177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications.
    Giacobbe DR; Giani T; Bassetti M; Marchese A; Viscoli C; Rossolini GM
    Clin Microbiol Infect; 2020 Jun; 26(6):713-722. PubMed ID: 31610299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerate Pheno™ blood culture detection system: a literature review.
    Cenci E; Paggi R; Socio GV; Bozza S; Camilloni B; Pietrella D; Mencacci A
    Future Microbiol; 2020 Oct; 15():1595-1605. PubMed ID: 33215528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST.
    Anton-Vazquez V; Adjepong S; Suarez C; Planche T
    BMC Microbiol; 2019 Nov; 19(1):268. PubMed ID: 31783787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.
    Lutgring JD; Bittencourt C; McElvania TeKippe E; Cavuoti D; Hollaway R; Burd EM
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance and potential clinical impact of Alfred60
    Van den Poel B; Meersseman P; Debaveye Y; Klak A; Verhaegen J; Desmet S
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):53-63. PubMed ID: 31624985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Performance and Impact of Accelerate Pheno for Gram-negative Bacteremia in Hospitalized Children.
    Lee M; Scardina T; Zheng X; Patel SJ
    Clin Ther; 2020 Sep; 42(9):1630-1636. PubMed ID: 32826063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antimicrobial stewardship and rapid microarray testing on patients with Gram-negative bacteremia.
    Rivard KR; Athans V; Lam SW; Gordon SM; Procop GW; Richter SS; Neuner E
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1879-1887. PubMed ID: 28534213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Effect of Expedited Pathogen Identification and Susceptibility Testing for Gram-Negative Bacteremia and Candidemia by Use of the Accelerate Pheno
    Burnham JP; Wallace MA; Fuller BM; Shupe A; Burnham CD; Kollef MH
    J Appl Lab Med; 2019 Jan; 3(4):569-579. PubMed ID: 31639726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.